SCHEMBL4850165

SCHEMBL4850165

COc1ccc(C(=O)C=Cc2cc(-c3ccccc3C)ccc2OCCN(C)C)c(OC)c1OC

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 2/20 0.48
CHRNA7 P36544 1/20 0.46
TUBB1 Q9H4B7 3/20 0.46
MCL1 Q07820 3/20 0.43
SLC6A9 P48067 2/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP1B1 Q16678 1/20 0.42
ALOX5 P09917 1/20 0.42
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
MCHR1 Q99705 2/20 0.42
HTR7 P34969 1/20 0.41
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845636 0.93 TNFRSF1A (0.49) TNFRSF1ACHRNA7TUBB1MCL1SLC6A9
SCHEMBL4853325 0.91 CHRNA7 (0.51) CHRNA7SLC6A9CYP1A1CYP1A2CYP1B1
SCHEMBL4850162 0.91 CHRNA7 (0.51) CHRNA7SLC6A9CYP1A1CYP1A2CYP1B1
SCHEMBL4848206 0.91 MCL1 (0.50) TNFRSF1ACHRNA7TUBB1MCL1SLC6A9
SCHEMBL4845551 0.89 MCHR1 (0.49) TNFRSF1ACHRNA7TUBB1MCL1SLC6A9
SCHEMBL4851981 0.86 CHRNA7 (0.46) TNFRSF1ACHRNA7TUBB1MCL1CYP1A1
SCHEMBL4848487 0.85 LMNA (0.46) TNFRSF1ATUBB1SLC6A9ALDH1A1
SCHEMBL4848038 0.85 ABCG2 (0.47) TNFRSF1ASLC6A9
SCHEMBL4852831 0.85 TUBB1 (0.50) TNFRSF1ACHRNA7TUBB1MCL1CYP1A1
SCHEMBL4849390 0.84 ALDH1A1 (0.52) TNFRSF1ACHRNA7TUBB1CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed